nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Cefazolin—PON1—atherosclerosis	0.00889	0.453	CrCbGaD
Cefpodoxime—Cefdinir—MPO—atherosclerosis	0.00364	0.185	CrCbGaD
Cefpodoxime—Cefaclor—MPO—atherosclerosis	0.0036	0.184	CrCbGaD
Cefpodoxime—Stomatitis—Niacin—atherosclerosis	0.0034	0.00347	CcSEcCtD
Cefpodoxime—Erythema multiforme—Ezetimibe—atherosclerosis	0.00338	0.00345	CcSEcCtD
Cefpodoxime—Chills—Lovastatin—atherosclerosis	0.00327	0.00334	CcSEcCtD
Cefpodoxime—Cough—Rosuvastatin—atherosclerosis	0.00327	0.00333	CcSEcCtD
Cefpodoxime—Erythema multiforme—Simvastatin—atherosclerosis	0.00322	0.00329	CcSEcCtD
Cefpodoxime—Sinusitis—Pravastatin—atherosclerosis	0.00322	0.00329	CcSEcCtD
Cefpodoxime—Alopecia—Lovastatin—atherosclerosis	0.00322	0.00328	CcSEcCtD
Cefpodoxime—Myalgia—Rosuvastatin—atherosclerosis	0.00319	0.00325	CcSEcCtD
Cefpodoxime—Alopecia—Ezetimibe—atherosclerosis	0.00316	0.00322	CcSEcCtD
Cefpodoxime—Haemoglobin—Niacin—atherosclerosis	0.00315	0.00321	CcSEcCtD
Cefpodoxime—Rhinitis—Niacin—atherosclerosis	0.00314	0.0032	CcSEcCtD
Cefpodoxime—Haemorrhage—Niacin—atherosclerosis	0.00313	0.00319	CcSEcCtD
Cefpodoxime—Flatulence—Lovastatin—atherosclerosis	0.00313	0.00319	CcSEcCtD
Cefpodoxime—Dysgeusia—Lovastatin—atherosclerosis	0.00311	0.00317	CcSEcCtD
Cefpodoxime—Rhinitis—Pravastatin—atherosclerosis	0.00309	0.00315	CcSEcCtD
Cefpodoxime—Oedema peripheral—Niacin—atherosclerosis	0.00308	0.00315	CcSEcCtD
Cefpodoxime—Confusional state—Rosuvastatin—atherosclerosis	0.00308	0.00314	CcSEcCtD
Cefpodoxime—Back pain—Lovastatin—atherosclerosis	0.00307	0.00313	CcSEcCtD
Cefpodoxime—Flatulence—Ezetimibe—atherosclerosis	0.00307	0.00313	CcSEcCtD
Cefpodoxime—Chills—Simvastatin—atherosclerosis	0.00306	0.00312	CcSEcCtD
Cefpodoxime—Alopecia—Simvastatin—atherosclerosis	0.00301	0.00307	CcSEcCtD
Cefpodoxime—Back pain—Ezetimibe—atherosclerosis	0.00301	0.00307	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00299	0.00305	CcSEcCtD
Cefpodoxime—Tremor—Lovastatin—atherosclerosis	0.00297	0.00303	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Lovastatin—atherosclerosis	0.00294	0.003	CcSEcCtD
Cefpodoxime—Flatulence—Simvastatin—atherosclerosis	0.00292	0.00298	CcSEcCtD
Cefpodoxime—Tinnitus—Niacin—atherosclerosis	0.00292	0.00298	CcSEcCtD
Cefpodoxime—Erythema multiforme—Pravastatin—atherosclerosis	0.00291	0.00297	CcSEcCtD
Cefpodoxime—Dysgeusia—Simvastatin—atherosclerosis	0.00291	0.00296	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00289	0.00294	CcSEcCtD
Cefpodoxime—Anaemia—Ezetimibe—atherosclerosis	0.00288	0.00293	CcSEcCtD
Cefpodoxime—Tinnitus—Pravastatin—atherosclerosis	0.00287	0.00293	CcSEcCtD
Cefpodoxime—Malaise—Lovastatin—atherosclerosis	0.00286	0.00292	CcSEcCtD
Cefpodoxime—Vertigo—Lovastatin—atherosclerosis	0.00285	0.00291	CcSEcCtD
Cefpodoxime—Leukopenia—Lovastatin—atherosclerosis	0.00284	0.0029	CcSEcCtD
Cefpodoxime—Chills—Niacin—atherosclerosis	0.00281	0.00286	CcSEcCtD
Cefpodoxime—Malaise—Ezetimibe—atherosclerosis	0.00281	0.00286	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00278	0.00284	CcSEcCtD
Cefpodoxime—Tremor—Simvastatin—atherosclerosis	0.00278	0.00284	CcSEcCtD
Cefpodoxime—Alopecia—Niacin—atherosclerosis	0.00277	0.00282	CcSEcCtD
Cefpodoxime—Chills—Pravastatin—atherosclerosis	0.00277	0.00282	CcSEcCtD
Cefpodoxime—Insomnia—Rosuvastatin—atherosclerosis	0.00276	0.00282	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Simvastatin—atherosclerosis	0.00275	0.00281	CcSEcCtD
Cefpodoxime—Palpitations—Ezetimibe—atherosclerosis	0.00275	0.0028	CcSEcCtD
Cefpodoxime—Paraesthesia—Rosuvastatin—atherosclerosis	0.00274	0.0028	CcSEcCtD
Cefpodoxime—Anaemia—Simvastatin—atherosclerosis	0.00274	0.0028	CcSEcCtD
Cefpodoxime—Alopecia—Pravastatin—atherosclerosis	0.00272	0.00278	CcSEcCtD
Cefpodoxime—Cough—Ezetimibe—atherosclerosis	0.00272	0.00277	CcSEcCtD
Cefpodoxime—Chest pain—Lovastatin—atherosclerosis	0.0027	0.00275	CcSEcCtD
Cefpodoxime—Myalgia—Lovastatin—atherosclerosis	0.0027	0.00275	CcSEcCtD
Cefpodoxime—Anxiety—Lovastatin—atherosclerosis	0.00269	0.00275	CcSEcCtD
Cefpodoxime—Dyspepsia—Rosuvastatin—atherosclerosis	0.00269	0.00274	CcSEcCtD
Cefpodoxime—Hypertension—Ezetimibe—atherosclerosis	0.00269	0.00274	CcSEcCtD
Cefpodoxime—Flatulence—Niacin—atherosclerosis	0.00268	0.00274	CcSEcCtD
Cefpodoxime—Malaise—Simvastatin—atherosclerosis	0.00268	0.00273	CcSEcCtD
Cefpodoxime—Tension—Niacin—atherosclerosis	0.00267	0.00273	CcSEcCtD
Cefpodoxime—Discomfort—Lovastatin—atherosclerosis	0.00267	0.00272	CcSEcCtD
Cefpodoxime—Vertigo—Simvastatin—atherosclerosis	0.00267	0.00272	CcSEcCtD
Cefpodoxime—Leukopenia—Simvastatin—atherosclerosis	0.00266	0.00271	CcSEcCtD
Cefpodoxime—Myalgia—Ezetimibe—atherosclerosis	0.00265	0.0027	CcSEcCtD
Cefpodoxime—Chest pain—Ezetimibe—atherosclerosis	0.00265	0.0027	CcSEcCtD
Cefpodoxime—Nervousness—Niacin—atherosclerosis	0.00265	0.0027	CcSEcCtD
Cefpodoxime—Flatulence—Pravastatin—atherosclerosis	0.00264	0.0027	CcSEcCtD
Cefpodoxime—Dry mouth—Lovastatin—atherosclerosis	0.00264	0.00269	CcSEcCtD
Cefpodoxime—Tension—Pravastatin—atherosclerosis	0.00263	0.00269	CcSEcCtD
Cefpodoxime—Dysgeusia—Pravastatin—atherosclerosis	0.00263	0.00268	CcSEcCtD
Cefpodoxime—Discomfort—Ezetimibe—atherosclerosis	0.00262	0.00267	CcSEcCtD
Cefpodoxime—Pain—Rosuvastatin—atherosclerosis	0.00261	0.00266	CcSEcCtD
Cefpodoxime—Constipation—Rosuvastatin—atherosclerosis	0.00261	0.00266	CcSEcCtD
Cefpodoxime—Confusional state—Lovastatin—atherosclerosis	0.00261	0.00266	CcSEcCtD
Cefpodoxime—Nervousness—Pravastatin—atherosclerosis	0.00261	0.00266	CcSEcCtD
Cefpodoxime—Dry mouth—Ezetimibe—atherosclerosis	0.00259	0.00264	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Lovastatin—atherosclerosis	0.00259	0.00264	CcSEcCtD
Cefpodoxime—Confusional state—Ezetimibe—atherosclerosis	0.00256	0.00261	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00254	0.00259	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Lovastatin—atherosclerosis	0.00253	0.00259	CcSEcCtD
Cefpodoxime—Chest pain—Simvastatin—atherosclerosis	0.00253	0.00258	CcSEcCtD
Cefpodoxime—Myalgia—Simvastatin—atherosclerosis	0.00253	0.00258	CcSEcCtD
Cefpodoxime—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00252	0.00257	CcSEcCtD
Cefpodoxime—Anxiety—Simvastatin—atherosclerosis	0.00252	0.00257	CcSEcCtD
Cefpodoxime—Tremor—Pravastatin—atherosclerosis	0.00251	0.00256	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.0025	0.00255	CcSEcCtD
Cefpodoxime—Discomfort—Simvastatin—atherosclerosis	0.0025	0.00255	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Pravastatin—atherosclerosis	0.00249	0.00254	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00249	0.00254	CcSEcCtD
Cefpodoxime—Anaemia—Pravastatin—atherosclerosis	0.00248	0.00253	CcSEcCtD
Cefpodoxime—Anorexia—Lovastatin—atherosclerosis	0.00247	0.00252	CcSEcCtD
Cefpodoxime—Vertigo—Niacin—atherosclerosis	0.00245	0.0025	CcSEcCtD
Cefpodoxime—Syncope—Niacin—atherosclerosis	0.00244	0.00249	CcSEcCtD
Cefpodoxime—Confusional state—Simvastatin—atherosclerosis	0.00244	0.00249	CcSEcCtD
Cefpodoxime—Leukopenia—Niacin—atherosclerosis	0.00244	0.00249	CcSEcCtD
Cefpodoxime—Urticaria—Rosuvastatin—atherosclerosis	0.00243	0.00248	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Simvastatin—atherosclerosis	0.00242	0.00247	CcSEcCtD
Cefpodoxime—Malaise—Pravastatin—atherosclerosis	0.00242	0.00247	CcSEcCtD
Cefpodoxime—Abdominal pain—Rosuvastatin—atherosclerosis	0.00242	0.00246	CcSEcCtD
Cefpodoxime—Vertigo—Pravastatin—atherosclerosis	0.00241	0.00246	CcSEcCtD
Cefpodoxime—Palpitations—Niacin—atherosclerosis	0.00241	0.00246	CcSEcCtD
Cefpodoxime—Leukopenia—Pravastatin—atherosclerosis	0.0024	0.00245	CcSEcCtD
Cefpodoxime—Loss of consciousness—Niacin—atherosclerosis	0.00239	0.00244	CcSEcCtD
Cefpodoxime—Cough—Niacin—atherosclerosis	0.00238	0.00243	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Simvastatin—atherosclerosis	0.00237	0.00242	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00236	0.00241	CcSEcCtD
Cefpodoxime—Insomnia—Lovastatin—atherosclerosis	0.00234	0.00239	CcSEcCtD
Cefpodoxime—Cough—Pravastatin—atherosclerosis	0.00234	0.00239	CcSEcCtD
Cefpodoxime—Paraesthesia—Lovastatin—atherosclerosis	0.00232	0.00237	CcSEcCtD
Cefpodoxime—Myalgia—Niacin—atherosclerosis	0.00232	0.00237	CcSEcCtD
Cefpodoxime—Hypertension—Pravastatin—atherosclerosis	0.00232	0.00236	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00231	0.00236	CcSEcCtD
Cefpodoxime—Anorexia—Simvastatin—atherosclerosis	0.00231	0.00235	CcSEcCtD
Cefpodoxime—Dyspnoea—Lovastatin—atherosclerosis	0.00231	0.00235	CcSEcCtD
Cefpodoxime—Insomnia—Ezetimibe—atherosclerosis	0.0023	0.00234	CcSEcCtD
Cefpodoxime—Chest pain—Pravastatin—atherosclerosis	0.00228	0.00233	CcSEcCtD
Cefpodoxime—Myalgia—Pravastatin—atherosclerosis	0.00228	0.00233	CcSEcCtD
Cefpodoxime—Paraesthesia—Ezetimibe—atherosclerosis	0.00228	0.00233	CcSEcCtD
Cefpodoxime—Dyspepsia—Lovastatin—atherosclerosis	0.00228	0.00232	CcSEcCtD
Cefpodoxime—Anxiety—Pravastatin—atherosclerosis	0.00228	0.00232	CcSEcCtD
Cefpodoxime—Dry mouth—Niacin—atherosclerosis	0.00227	0.00231	CcSEcCtD
Cefpodoxime—Dyspnoea—Ezetimibe—atherosclerosis	0.00226	0.00231	CcSEcCtD
Cefpodoxime—Discomfort—Pravastatin—atherosclerosis	0.00226	0.0023	CcSEcCtD
Cefpodoxime—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00225	0.0023	CcSEcCtD
Cefpodoxime—Decreased appetite—Lovastatin—atherosclerosis	0.00225	0.0023	CcSEcCtD
Cefpodoxime—Dyspepsia—Ezetimibe—atherosclerosis	0.00224	0.00228	CcSEcCtD
Cefpodoxime—Fatigue—Lovastatin—atherosclerosis	0.00223	0.00228	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Niacin—atherosclerosis	0.00222	0.00227	CcSEcCtD
Cefpodoxime—Pain—Lovastatin—atherosclerosis	0.00221	0.00226	CcSEcCtD
Cefpodoxime—Constipation—Lovastatin—atherosclerosis	0.00221	0.00226	CcSEcCtD
Cefpodoxime—Confusional state—Pravastatin—atherosclerosis	0.00221	0.00225	CcSEcCtD
Cefpodoxime—Decreased appetite—Ezetimibe—atherosclerosis	0.00221	0.00225	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00221	0.00225	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00219	0.00224	CcSEcCtD
Cefpodoxime—Asthenia—Rosuvastatin—atherosclerosis	0.00219	0.00224	CcSEcCtD
Cefpodoxime—Insomnia—Simvastatin—atherosclerosis	0.00219	0.00223	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Pravastatin—atherosclerosis	0.00219	0.00223	CcSEcCtD
Cefpodoxime—Fatigue—Ezetimibe—atherosclerosis	0.00219	0.00223	CcSEcCtD
Cefpodoxime—Shock—Niacin—atherosclerosis	0.00219	0.00223	CcSEcCtD
Cefpodoxime—Paraesthesia—Simvastatin—atherosclerosis	0.00217	0.00222	CcSEcCtD
Cefpodoxime—Constipation—Ezetimibe—atherosclerosis	0.00217	0.00222	CcSEcCtD
Cefpodoxime—Pain—Ezetimibe—atherosclerosis	0.00217	0.00222	CcSEcCtD
Cefpodoxime—Pruritus—Rosuvastatin—atherosclerosis	0.00216	0.0022	CcSEcCtD
Cefpodoxime—Dyspnoea—Simvastatin—atherosclerosis	0.00216	0.0022	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Niacin—atherosclerosis	0.00215	0.00219	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Pravastatin—atherosclerosis	0.00214	0.00219	CcSEcCtD
Cefpodoxime—Feeling abnormal—Lovastatin—atherosclerosis	0.00213	0.00218	CcSEcCtD
Cefpodoxime—Dyspepsia—Simvastatin—atherosclerosis	0.00213	0.00217	CcSEcCtD
Cefpodoxime—Anorexia—Niacin—atherosclerosis	0.00212	0.00216	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00212	0.00216	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Pravastatin—atherosclerosis	0.00212	0.00216	CcSEcCtD
Cefpodoxime—Decreased appetite—Simvastatin—atherosclerosis	0.00211	0.00215	CcSEcCtD
Cefpodoxime—Feeling abnormal—Ezetimibe—atherosclerosis	0.00209	0.00213	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00209	0.00213	CcSEcCtD
Cefpodoxime—Diarrhoea—Rosuvastatin—atherosclerosis	0.00209	0.00213	CcSEcCtD
Cefpodoxime—Fatigue—Simvastatin—atherosclerosis	0.00209	0.00213	CcSEcCtD
Cefpodoxime—Anorexia—Pravastatin—atherosclerosis	0.00209	0.00213	CcSEcCtD
Cefpodoxime—Hypotension—Niacin—atherosclerosis	0.00208	0.00212	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00208	0.00212	CcSEcCtD
Cefpodoxime—Constipation—Simvastatin—atherosclerosis	0.00207	0.00211	CcSEcCtD
Cefpodoxime—Pain—Simvastatin—atherosclerosis	0.00207	0.00211	CcSEcCtD
Cefpodoxime—Urticaria—Lovastatin—atherosclerosis	0.00206	0.0021	CcSEcCtD
Cefpodoxime—Abdominal pain—Lovastatin—atherosclerosis	0.00205	0.00209	CcSEcCtD
Cefpodoxime—Body temperature increased—Lovastatin—atherosclerosis	0.00205	0.00209	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00203	0.00207	CcSEcCtD
Cefpodoxime—Dizziness—Rosuvastatin—atherosclerosis	0.00202	0.00206	CcSEcCtD
Cefpodoxime—Urticaria—Ezetimibe—atherosclerosis	0.00202	0.00206	CcSEcCtD
Cefpodoxime—Insomnia—Niacin—atherosclerosis	0.00201	0.00205	CcSEcCtD
Cefpodoxime—Abdominal pain—Ezetimibe—atherosclerosis	0.00201	0.00205	CcSEcCtD
Cefpodoxime—Body temperature increased—Ezetimibe—atherosclerosis	0.00201	0.00205	CcSEcCtD
Cefpodoxime—Paraesthesia—Niacin—atherosclerosis	0.002	0.00204	CcSEcCtD
Cefpodoxime—Feeling abnormal—Simvastatin—atherosclerosis	0.002	0.00204	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00199	0.00203	CcSEcCtD
Cefpodoxime—Dyspnoea—Niacin—atherosclerosis	0.00198	0.00202	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00198	0.00202	CcSEcCtD
Cefpodoxime—Insomnia—Pravastatin—atherosclerosis	0.00198	0.00202	CcSEcCtD
Cefpodoxime—Somnolence—Niacin—atherosclerosis	0.00198	0.00202	CcSEcCtD
Cefpodoxime—Paraesthesia—Pravastatin—atherosclerosis	0.00197	0.00201	CcSEcCtD
Cefpodoxime—Dyspepsia—Niacin—atherosclerosis	0.00196	0.002	CcSEcCtD
Cefpodoxime—Dyspnoea—Pravastatin—atherosclerosis	0.00195	0.00199	CcSEcCtD
Cefpodoxime—Decreased appetite—Niacin—atherosclerosis	0.00193	0.00197	CcSEcCtD
Cefpodoxime—Dyspepsia—Pravastatin—atherosclerosis	0.00193	0.00197	CcSEcCtD
Cefpodoxime—Rash—Rosuvastatin—atherosclerosis	0.00193	0.00196	CcSEcCtD
Cefpodoxime—Dermatitis—Rosuvastatin—atherosclerosis	0.00192	0.00196	CcSEcCtD
Cefpodoxime—Urticaria—Simvastatin—atherosclerosis	0.00192	0.00196	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Niacin—atherosclerosis	0.00192	0.00196	CcSEcCtD
Cefpodoxime—Abdominal pain—Simvastatin—atherosclerosis	0.00191	0.00195	CcSEcCtD
Cefpodoxime—Body temperature increased—Simvastatin—atherosclerosis	0.00191	0.00195	CcSEcCtD
Cefpodoxime—Headache—Rosuvastatin—atherosclerosis	0.00191	0.00195	CcSEcCtD
Cefpodoxime—Hypersensitivity—Lovastatin—atherosclerosis	0.00191	0.00195	CcSEcCtD
Cefpodoxime—Decreased appetite—Pravastatin—atherosclerosis	0.0019	0.00194	CcSEcCtD
Cefpodoxime—Pain—Niacin—atherosclerosis	0.0019	0.00194	CcSEcCtD
Cefpodoxime—Fatigue—Pravastatin—atherosclerosis	0.00189	0.00193	CcSEcCtD
Cefpodoxime—Pain—Pravastatin—atherosclerosis	0.00187	0.00191	CcSEcCtD
Cefpodoxime—Constipation—Pravastatin—atherosclerosis	0.00187	0.00191	CcSEcCtD
Cefpodoxime—Hypersensitivity—Ezetimibe—atherosclerosis	0.00187	0.00191	CcSEcCtD
Cefpodoxime—Asthenia—Lovastatin—atherosclerosis	0.00186	0.00189	CcSEcCtD
Cefpodoxime—Pruritus—Lovastatin—atherosclerosis	0.00183	0.00187	CcSEcCtD
Cefpodoxime—Asthenia—Ezetimibe—atherosclerosis	0.00182	0.00186	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Niacin—atherosclerosis	0.00182	0.00185	CcSEcCtD
Cefpodoxime—Nausea—Rosuvastatin—atherosclerosis	0.00181	0.00185	CcSEcCtD
Cefpodoxime—Feeling abnormal—Pravastatin—atherosclerosis	0.0018	0.00184	CcSEcCtD
Cefpodoxime—Pruritus—Ezetimibe—atherosclerosis	0.0018	0.00183	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00179	0.00183	CcSEcCtD
Cefpodoxime—Hypersensitivity—Simvastatin—atherosclerosis	0.00178	0.00182	CcSEcCtD
Cefpodoxime—Diarrhoea—Lovastatin—atherosclerosis	0.00177	0.00181	CcSEcCtD
Cefpodoxime—Urticaria—Niacin—atherosclerosis	0.00177	0.0018	CcSEcCtD
Cefpodoxime—Body temperature increased—Niacin—atherosclerosis	0.00176	0.00179	CcSEcCtD
Cefpodoxime—Abdominal pain—Niacin—atherosclerosis	0.00176	0.00179	CcSEcCtD
Cefpodoxime—Urticaria—Pravastatin—atherosclerosis	0.00174	0.00177	CcSEcCtD
Cefpodoxime—Asthenia—Simvastatin—atherosclerosis	0.00174	0.00177	CcSEcCtD
Cefpodoxime—Diarrhoea—Ezetimibe—atherosclerosis	0.00174	0.00177	CcSEcCtD
Cefpodoxime—Abdominal pain—Pravastatin—atherosclerosis	0.00173	0.00177	CcSEcCtD
Cefpodoxime—Body temperature increased—Pravastatin—atherosclerosis	0.00173	0.00177	CcSEcCtD
Cefpodoxime—Pruritus—Simvastatin—atherosclerosis	0.00171	0.00175	CcSEcCtD
Cefpodoxime—Dizziness—Lovastatin—atherosclerosis	0.00171	0.00175	CcSEcCtD
Cefpodoxime—Dizziness—Ezetimibe—atherosclerosis	0.00168	0.00171	CcSEcCtD
Cefpodoxime—Diarrhoea—Simvastatin—atherosclerosis	0.00166	0.00169	CcSEcCtD
Cefpodoxime—Vomiting—Lovastatin—atherosclerosis	0.00165	0.00168	CcSEcCtD
Cefpodoxime—Hypersensitivity—Niacin—atherosclerosis	0.00164	0.00167	CcSEcCtD
Cefpodoxime—Rash—Lovastatin—atherosclerosis	0.00163	0.00167	CcSEcCtD
Cefpodoxime—Dermatitis—Lovastatin—atherosclerosis	0.00163	0.00166	CcSEcCtD
Cefpodoxime—Headache—Lovastatin—atherosclerosis	0.00162	0.00165	CcSEcCtD
Cefpodoxime—Vomiting—Ezetimibe—atherosclerosis	0.00161	0.00165	CcSEcCtD
Cefpodoxime—Hypersensitivity—Pravastatin—atherosclerosis	0.00161	0.00165	CcSEcCtD
Cefpodoxime—Dizziness—Simvastatin—atherosclerosis	0.0016	0.00163	CcSEcCtD
Cefpodoxime—Rash—Ezetimibe—atherosclerosis	0.0016	0.00163	CcSEcCtD
Cefpodoxime—Dermatitis—Ezetimibe—atherosclerosis	0.0016	0.00163	CcSEcCtD
Cefpodoxime—Asthenia—Niacin—atherosclerosis	0.0016	0.00163	CcSEcCtD
Cefpodoxime—Headache—Ezetimibe—atherosclerosis	0.00159	0.00162	CcSEcCtD
Cefpodoxime—Pruritus—Niacin—atherosclerosis	0.00157	0.0016	CcSEcCtD
Cefpodoxime—Asthenia—Pravastatin—atherosclerosis	0.00157	0.0016	CcSEcCtD
Cefpodoxime—Pruritus—Pravastatin—atherosclerosis	0.00155	0.00158	CcSEcCtD
Cefpodoxime—Vomiting—Simvastatin—atherosclerosis	0.00154	0.00157	CcSEcCtD
Cefpodoxime—Nausea—Lovastatin—atherosclerosis	0.00154	0.00157	CcSEcCtD
Cefpodoxime—Rash—Simvastatin—atherosclerosis	0.00153	0.00156	CcSEcCtD
Cefpodoxime—Dermatitis—Simvastatin—atherosclerosis	0.00153	0.00156	CcSEcCtD
Cefpodoxime—Diarrhoea—Niacin—atherosclerosis	0.00152	0.00155	CcSEcCtD
Cefpodoxime—Headache—Simvastatin—atherosclerosis	0.00152	0.00155	CcSEcCtD
Cefpodoxime—Nausea—Ezetimibe—atherosclerosis	0.00151	0.00154	CcSEcCtD
Cefpodoxime—Diarrhoea—Pravastatin—atherosclerosis	0.0015	0.00153	CcSEcCtD
Cefpodoxime—Dizziness—Niacin—atherosclerosis	0.00147	0.0015	CcSEcCtD
Cefpodoxime—Dizziness—Pravastatin—atherosclerosis	0.00145	0.00148	CcSEcCtD
Cefpodoxime—Nausea—Simvastatin—atherosclerosis	0.00144	0.00147	CcSEcCtD
Cefpodoxime—Vomiting—Niacin—atherosclerosis	0.00141	0.00144	CcSEcCtD
Cefpodoxime—Rash—Niacin—atherosclerosis	0.0014	0.00143	CcSEcCtD
Cefpodoxime—Dermatitis—Niacin—atherosclerosis	0.0014	0.00143	CcSEcCtD
Cefpodoxime—Headache—Niacin—atherosclerosis	0.00139	0.00142	CcSEcCtD
Cefpodoxime—Vomiting—Pravastatin—atherosclerosis	0.00139	0.00142	CcSEcCtD
Cefpodoxime—Rash—Pravastatin—atherosclerosis	0.00138	0.00141	CcSEcCtD
Cefpodoxime—Dermatitis—Pravastatin—atherosclerosis	0.00138	0.00141	CcSEcCtD
Cefpodoxime—Headache—Pravastatin—atherosclerosis	0.00137	0.0014	CcSEcCtD
Cefpodoxime—Nausea—Niacin—atherosclerosis	0.00132	0.00135	CcSEcCtD
Cefpodoxime—Nausea—Pravastatin—atherosclerosis	0.0013	0.00133	CcSEcCtD
Cefpodoxime—Cefazolin—ALB—atherosclerosis	0.000989	0.0504	CrCbGaD
Cefpodoxime—Ceftriaxone—ALB—atherosclerosis	0.000938	0.0478	CrCbGaD
Cefpodoxime—Cefalotin—ALB—atherosclerosis	0.000821	0.0419	CrCbGaD
Cefpodoxime—Cephalexin—ALB—atherosclerosis	0.000747	0.0381	CrCbGaD
